NFKB1 and hepatocellular carcinoma: In hepatocellular carcinoma, the PNU-74654 treatment of HepG2 and Huh7 cells suppressed NF-κB pathway activity, thereby interfering with the cell cycle and promoting antiproliferative and antimigration effects [25].